Related Experiment Video
Updated: Jun 17, 2026

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus
1Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. horiy@med.kobe-u.ac.jp
Abstract:
One of the most common diseases of the pancreas is diabetes mellitus. The current treatment of exogenous insulin supply is not fully capable of achieving tight control of glucose regulation, leading to long-term complications. Hence, recent success in islet transplantation-based therapies for diabetes mellitus and the extreme shortage of pancreatic islets have motivated recent efforts to develop renewable sources of islet-replacement tissue. Of clinical interest, I review the recent progress on stem cell-based strategies for diabetes in view of regenerative medicine.
Insights
Stem cell strategies offer a promising solution for diabetes mellitus, addressing the shortage of pancreatic islets for transplantation and improving glucose regulation. This review explores recent advancements in regenerative medicine for diabetes treatment.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Cell Biology
Background:
- Diabetes mellitus is a prevalent pancreatic disease.
- Current insulin therapy has limitations in glucose control, leading to complications.
- There is a critical shortage of pancreatic islets for transplantation.
Purpose of the Study:
- To review recent progress in stem cell-based strategies for diabetes.
- To explore the potential of regenerative medicine in diabetes treatment.
Main Methods:
- Literature review of stem cell-based therapies for diabetes.
- Analysis of recent advancements in islet-replacement tissue development.
Main Results:
- Stem cell-based approaches are emerging as a viable alternative for diabetes treatment.
- Progress has been made in developing renewable sources of islet-replacement tissue.
Conclusions:
- Stem cell strategies hold significant promise for the future treatment of diabetes mellitus.
- Regenerative medicine offers a pathway to overcome the limitations of current diabetes therapies.
Related Concept Videos
iPS Cell Differentiation
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
